Invitrogen™ Human IL-17 RB ELISA Kit

Ref.: BL-RE-092626Manufacturer ref.: EH261RB 96 tests
€734.00 excl. VAT

Human IL-17 RB quantitates human IL-17 RB in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human IL-17 RB.

Accession number
CRL4 ; récepteur de cytokine CRL4 ; récepteur de cytokine analogue 4 ; site d’intégration virale écotropique 27 ; Evi27 ; récepteur d’IL-17 B ; récepteur d’IL-17 homologue 1 ; IL-17 B ; récepteur d’IL-17 B ; IL17BR ; IL-17 ER ; IL17RB ; IL-17 RB ; IL17RH1 ; IL-17 Rh1 ; IL-20 ; récepteur de l’interleukine 17 B ; récepteur de l’interleukine 17 homologue 1 ; récepteur de l’interleukine 17 B ; récepteur de l’interleukine-17 B ; récepteur de l’interleukine-17 B ; MGC138900 ; MGC138901 ; MGC5245 ; UNQ2501/PRO19612 ; ZCYTO7
Dose range
0.85 to 200 ng/ml
Sensitivity of the dosage
0.85 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human IL-17 RB quantitates human IL-17 RB in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human IL-17 RB.

Human IL-17 RB quantitates human IL-17 RB in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human IL-17 RB.

Recently, a number of cytokines belonging to the interleukin family (IL)-17 have been identified. They are called IL-17B, IL-17C (1) and IL-17E. The IL-17 is a potent pro-inflammatory cytokine that plays a role in a number of diseases, including rheumatoid arthritis, multiple sclerosis and the promotion of tumour growth. IL-17B, C and E as IL-17 are able to induce pro-inflammatory responses. However, they do not bind to the IL-17 receptor, suggesting that there may be an additional receptor bound to the IL-17R. The receptors of the IL-17B and the IL-17E were isolated independently and designated as EV127 (mouse) and IL-17Rh1 (male), respectively. The IL-17E induces activation of the NF-kB pathway and, like the IL-17, also induces production of the IL-8. The mRNA of the IL-17Rh1 is strongly expressed in the kidney and liver and at a moderate level in the small intestine, colon and brain.

Sensitivity

Sensitivity of dosage: 0.85 ng/ml.

Measurement range

Dose range: 0.85 to 200 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: IL17RB.

Samples

Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; plasma, 50 µl; serum, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17144553
Specifications
Accession numberCRL4; CRL4 cytokine receptor; analogue cytokine receptor 4; ecotropic viral integration site 27; Evi27; receiver d íl-17 B; receiver d íl-17 homologous 1; IL-17 B; receiver d Ιl-17 B; IL17BR; IL-17 ER; IL17RB; IL-17 RB; IL17RH1; IL-17 Rh1; IL-20; interle receptor
Dose range0.85 to 200 ng/ml
Sensitivity of the dosage0.85 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)Q9NRM6
Gene symbol(s)IL17RB
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity96 tests
Regulatory statusUse exclusively for research
TargetIL17RB
Test time1 h 20 min
Physical characteristics
Volume of sampleSupernatant, 50 µl; plasma, 50 µl; serum, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH261RB
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.